FABP4 and colorectal carcinoma: When we dichotomized BMI into obesity (BMI ≥30 kg/m2) versus non‐obesity (BMI <30 kg/m2), the MP by FABP‐4 was higher for CRC‐specific mortality (38.5%, p = .005) than for non‐CRC‐specific mortality (21.9%, p = .03) (Table S6).